• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

These tiny fibers may prove better at delivering drugs to the brain

June 5, 2020 By Chris Newmarker

tiny fibers PLGA brain Martin Luther University Halle-Wittenberg drug delivery brain
[Image courtesy of Johanna Zech, for Martin Luther University Halle-Wittenberg]
German researchers have developed mats made of biodegradable fibers only a few microns thick that could prove advantageous to deliver certain drugs to the brain.

The drug nimodipine, for example, could prevent nerve cells from dying after brain surgery. Health providers already use it to treat cerebral hemorrhages, but it degrades very quickly and has undesirable side effects when delivered intravenously, according to the research team out of Martin Luther University Halle-Wittenberg and University Hospital Halle.

“The neurosurgeons wanted the drug to be applied locally in order to reduce potential side effects,” said professor Karsten Mäder from the Institute of Pharmacy at MLU.

Mäder and his colleagues turned to PLGA, a biodegradable polymer commonly used in medtech, and incorporating nimodipine into the polymer matrix. They developed a method of electrospinning the material into mats made of fibers only 1 to 2 μm thick. Tests on brain cells in vitro demonstrated a sustained drug release over four to eight days, dependent on release conditions, according to the researchers’ paper, recently published in the European Journal of Pharmaceutics and Biopharmaceutics.

The brain cell tests, conducted by the neurosurgery department at University Hospital Halle, found no toxic effects. Under various stress conditions, such as heat or high salt concentrations, the PLGA mats with nimodipine reduced the number of cell deaths, in some cases drastically, with nerve cells particularly benefitting.

The researchers’ paper notes one hitch: They tried electron beam sterilization on the fiber mats, but it reduced drug content considerably.

Still, the fiber mats hold some promise when it comes to providing a way to deliver a drug to the brain — or even another part of the body — in a localized way.

“In the cell systems, we were able to show that the effect was as good as if we had added the active ingredient without the fibers, in other words intravenously,” said professor Christian Scheller at UKH.

 

Filed Under: Featured, Materials Testing, Neurological, Research & Development Tagged With: Martin Luther University Halle-Wittenberg, University Hospital Halle

IN CASE YOU MISSED IT

  • 8 drug delivery innovations you need to know
  • Axonics acquires Contura and its Bulkamid bulking agent for $235M
  • Lilly to add Welldoc app to future insulin pen
  • Kala Pharmaceuticals slides on missed Q4 projections
  • Semaglutide paired with behavioral therapy tripled weight loss in trial

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS